Inventors list
Assignees list
Classification tree browser
Top 100 Inventors
Top 100 Assignees
03rd week of 2021 patent applcation highlights part 9
Patent application number
Title
Published
20210015821
SALTS AND SOLID FORM OF A BTK INHIBITOR
2021-01-21
20210015822
SUBSTITUTED AMINO TRIAZOLES USEFUL AS CHITINASE INHIBITORS
2021-01-21
20210015823
COMPOSITIONS FOR DELIVERY OF REBOXETINE
2021-01-21
20210015824
NOVEL PHARMACEUTICAL USE OF THIOPHENE [3,2-D] PYRIMIDINE-4-KETONE COMPOUND
2021-01-21
20210015825
THERAMUTEIN MODULATORS
2021-01-21
20210015826
ANTICANCER PHARMACEUTICAL COMPOSITIONS FOR COMBINED THERAPY
2021-01-21
20210015827
CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONISTS
2021-01-21
20210015828
Mirtazapine for use in medication overuse headache based on tension-type headache
2021-01-21
20210015829
CYCLIC TREX1 INHIBITORS
2021-01-21
20210015830
COMPOSITION FOR INHIBITING REACTIVE OXYGEN SPECIES PRODUCTION
2021-01-21
20210015831
TOPICAL COMPOSITION
2021-01-21
20210015832
FORMULATION INCLUDING DOXYCYCLINE HYCLATE AND METHOD FOR ADMINISTERING THE SAME
2021-01-21
20210015833
ORAL SOFT GEL CAPSULE CONTAINING PSYCHEDELIC COMPOUND
2021-01-21
20210015834
NK-1 ANTAGONISTS FOR USE IN THE TREATMENT OF OCULAR PAIN
2021-01-21
20210015835
CROCIN-SORAFENIB COMBINATION THERAPY FOR LIVER CANCER
2021-01-21
20210015836
TOPICAL ANALGESIC
2021-01-21
20210015837
Method of Manufacturing an antiviral super treatment
2021-01-21
20210015838
Cytochrome P450 Enzyme Complexes And Methods Of Treatment Using The Same
2021-01-21
20210015839
Maintenance of Platelet Inhibition During Antiplatelet Therapy
2021-01-21
20210015840
PHARMACEUTICAL OR COSMETIC COMPOSITION FOR PREVENTING OR TREATING HAIR LOSS OR PROMOTING HAIR GROWTH
2021-01-21
20210015841
TREATMENT OF HCV INFECTED PATIENTS WITH CIRRHOSIS
2021-01-21
20210015842
METHOD OF TREATMENT
2021-01-21
20210015843
MicroRNA-based methods and assays for osteocarcinoma
2021-01-21
20210015844
COMPOSITION FOR PURIFICATION OF BIOFLUIDS
2021-01-21
20210015845
COMPOSITIONS AND METHODS FOR IMPROVED HONEY BEE HEALTH
2021-01-21
20210015846
HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS
2021-01-21
20210015847
SKIN PREPARATION COMPOSITION FOR EXTERNAL USE CONTAINING COMPLEX HYALURONIC ACID
2021-01-21
20210015848
COMPOSITIONS AND THEIR USE IN THE TREATMENT OF ENDOMETRIOSIS AND PAIN
2021-01-21
20210015849
TREATMENT OF BONE MARROW EDEMA (OEDEMA) WITH POLYSULFATED POLYSACCHARIDES
2021-01-21
20210015850
COMPOSITION FOR IMPROVING INTESTINAL BARRIER FUNCTION
2021-01-21
20210015851
ANTIMICROBIAL AND CLEANSING COMPOSITION CONSISTING OF A POLYMERIC BIGUANIDE AND EDTA
2021-01-21
20210015852
PLANT MEDIUM INCLUDING AN OXYGEN-ENABLED COMPOSITION
2021-01-21
20210015853
Mitochondrial Function using a Poly-Oxygenated Metal Hydroxide
2021-01-21
20210015854
CHEMOTHERAPEUTIC AGENT COMPRISING COMBINATION OF ALEXIDINE DIHYDROCHLORIDE AND SODIUM PENTABORATE PENTAHYDRATE
2021-01-21
20210015855
MINERAL SALT-SULFONIC ACID COMPOSITIONS AND METHODS OF USE
2021-01-21
20210015856
NANODIAMONDS AS ARTIFICIAL PROTEINS FOR REGULATION OF A CELL SIGNALLING SYSTEM
2021-01-21
20210015857
METHOD FOR IMMUNOTHERAPY DRUG TREATMENT
2021-01-21
20210015858
ANTIBODIES TO T CELL IMMUNORECEPTOR WITH IG AND ITIM DOMAINS (TIGIT) AND USES THEREOF
2021-01-21
20210015859
IMMUNOTHERAPIES USING ENHANCED iPSC DERIVED EFFECTOR CELLS
2021-01-21
20210015860
COMPOSITIONS AND METHODS OF USE FOR AUGMENTED IMMUNE RESPONSE AND CANCER THERAPY
2021-01-21
20210015861
CHIMERIC ANTIGEN RECEPTORS FOR TREATMENT OF NEURODEGENERATIVE DISEASES AND DISORDERS
2021-01-21
20210015862
METHODS FOR ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
2021-01-21
20210015863
COMPOSITIONS AND METHODS FOR DELIVERY OF IMMUNE CELLS TO TREAT UN-RESECTABLE OR NON-RESECTED TUMOR CELLS AND TUMOR RELAPSE
2021-01-21
20210015864
CHIMERIC TRANSMEMBRANE PROTEINS AND USES THEREOF
2021-01-21
20210015865
CHIMERIC ENGULFMENT RECEPTORS AND USES THEREOF FOR NEURODEGENERATIVE DISEASES
2021-01-21
20210015866
TISSUE RESIDENT MEMORY CELL PROFILES, AND USES THEREOF
2021-01-21
20210015867
LYMPHOCYTES EXPRESSING HETEROLOGOUS TARGETING CONSTRUCTS
2021-01-21
20210015868
METHODS OF MANUFACTURING GENETICALLY-MODIFIED LYMPHOCYTES
2021-01-21
20210015869
T CELLS EXPRESSING A RECOMBINANT RECEPTOR, RELATED POLYNUCLEOTIDES AND METHODS
2021-01-21
20210015870
BCMA-CAR-T CELLS
2021-01-21
20210015871
PROLINE-RICH POLYPEPTIDE COMPLEX FOR USE IN TREATMENT OF BDNF-DEPENDENT DISORDERS
2021-01-21
20210015872
PANCREATIC ENDOCRINE PROGENITOR CELL THERAPIES FOR THE TREATMENT OF OBESITY AND TYPE 2 DIABETES (T2D)
2021-01-21
20210015873
GLYCYRRHIZIN-GLYCOL CHITOSAN CONJUGATE-COATED IRON OXIDE NANOPARTICLES AND USE THEREOF
2021-01-21
20210015874
USE OF BIO-TRANSFORMED BEAR BILE POWDER IN PREPARATION OF ANTI-INFLAMMATORY DRUGS
2021-01-21
20210015875
NANOVESICLES DERIVED FROM ENHYDROBACTER BACTERIA, AND USE THEREOF
2021-01-21
20210015876
USE OF PASTEURIZED AKKERMANSIA FOR TREATING METABOLIC DISORDERS
2021-01-21
20210015877
LACTOBACILLUS FERMENTUM FOR TREATING FRUCTOSE-RELATED DISEASES
2021-01-21
20210015878
PERSONALIZED CANCER VACCINES
2021-01-21
20210015879
METHOD FOR PRESERVING PROBIOTIC COMPOSITION AND USE THEREOF
2021-01-21
20210015880
NIGELLA SATIVA OIL COMPOSITION
2021-01-21
20210015881
AGENT EXHIBITING ANTIARRHYTHMIC EFFECT
2021-01-21
20210015882
Pharmaceutical composition for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis and method for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis
2021-01-21
20210015883
A NOVEL SYNERGIC HERBAL FORMULATION FOR THE PREVENTION AND TREATMENT OF PRE-DIABETES, DIABETES AND OTHER INSULIN RESISTANCE CASES
2021-01-21
20210015884
MODIFIED OLIGONUCLEOTIDES AND METHODS OF USE
2021-01-21
20210015885
SMALL MOLECULE RAS INHIBITORS
2021-01-21
20210015886
COMPOSITION FOR IMPROVING MILD COGNITIVE IMPAIRMENT AND METHOD FOR IMPROVING MILD COGNITIVE IMPAIRMENT
2021-01-21
20210015887
METHODS FOR REDUCING OXIDATIVE DAMAGE
2021-01-21
20210015888
SUPRAMOLECULAR GLYCOSAMINOGLYCANS
2021-01-21
20210015889
METHODS OF DISRUPTING A BIOFILM AND/OR PREVENTING FORMATION OF SAME
2021-01-21
20210015890
COMPOSITION AND METHODS FOR PROMOTING AND TREATING CHRONIC WOUND HEALING
2021-01-21
20210015891
INTERLEUKIN-18 MIMICS AND METHODS OF USE
2021-01-21
20210015892
METHODS OF DIAGNOSING AND TREATING CERVICAL CANCER
2021-01-21
20210015893
METHODS AND COMPOSITIONS FOR TREATING ALCOHOLIC LIVER DISEASE
2021-01-21
20210015894
NUCLEIC ACID MOLECULES AND METHODS OF USING THE SAME
2021-01-21
20210015895
POLYPEPTIDES COMPRISING A MODIFIED BACTERIOPHAGE G3P AMINO ACID SEQUENCE LACKING A GLYCOSYLATION SIGNAL
2021-01-21
20210015896
ANTIGENIC EPSTEIN BARR VIRUS POLYPEPTIDES
2021-01-21
20210015897
METHODS TO PRODUCE PEPTIDES, POLYPEPTIDES OR CELLS FOR MODULATING IMMUNITY
2021-01-21
20210015898
RESCUING VOLTAGE-GATED SODIUM CHANNEL FUNCTION IN INHIBITORY NEURONS
2021-01-21
20210015899
METHODS AND COMPOSITIONS RELATING TO LUNG REPAIR
2021-01-21
20210015900
GLA DOMAINS AS THERAPEUTIC AGENTS
2021-01-21
20210015901
METHODS OF TREATMENT WITH PEGFILGRASTIM AND ROMIPLOSTIM
2021-01-21
20210015902
ANGIOPOIETIN-LIKE PROTEIN 8 POLYPEPTIDE FRAGMENTS AND COMPOSITIONS THEREOF
2021-01-21
20210015903
TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY
2021-01-21
20210015904
TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY
2021-01-21
20210015905
PHARMACEUTICAL COMPOSITION FOR TREATING KELOID AND USES THEREOF
2021-01-21
20210015906
ENZYME REPLACEMENT THERAPY FOR MUCOPOLYSACCHARIDOSIS IIID
2021-01-21
20210015907
COMPOSITIONS FOR REMODELING EXTRACELLULAR MATRIX AND METHODS OF USE THEREOF
2021-01-21
20210015908
METHODS FOR TREATING AND FOR INHIBITING PROGRESSION OF SEIZURES
2021-01-21
20210015909
ORAL DISSOLVING FILMS CONTAINING MICROENCAPSULATED VACCINES AND METHODS OF MAKING SAME
2021-01-21
20210015910
VACCINE COMPOSITION AGAINST STREPTOCOCCUS SUIS INFECTION
2021-01-21
20210015911
HEPATITIS B VACCINES AND USES OF THE SAME
2021-01-21
20210015912
TOPICAL HYPER-ALLERGENIC COMPOSITION AND METHOD OF TREATING USING THE SAME
2021-01-21
20210015913
IMMUNOPOTENTIATOR, FOOT-AND-MOUTH DISEASE INACTIVATED VACCINE AND PREPARATION METHOD THEREOF
2021-01-21
20210015914
METHODS AND COMPOSITIONS RELATED TO ACCELERATED HUMORAL AFFINITY
2021-01-21
20210015915
STING MODULATOR COMPOUNDS WITH SULFAMATE LINKAGES, AND METHODS OF MAKING AND USING
2021-01-21
20210015916
VACCINE DELIVERY METHOD
2021-01-21
20210015917
Combination Of The Application Of Antibodies For Immunostimulation Together With Glucocorticoids
2021-01-21
20210015918
TREATMENT WITH ANTI-VEGF ANTIBODIES
2021-01-21
20210015919
USES FOR AND ARTICLE OF MANUFACTURE INCLUDING HER2 DIMERIZATION INHIBITOR PERTUZUMAB
2021-01-21
20210015920
COMPOSITION AND METHODS FOR STABILIZING LIQUID PROTEIN FORMULATIONS
2021-01-21